Skip to main content
. 2022 Jan 11;9:20499361211069264. doi: 10.1177/20499361211069264

Table 2.

Frequency of symptoms and main clinical conditions at admission.

Total (N = 4670)
Frequency of symptoms at admission, n (%)
 Headache 2721 (58.3)
 Cough 2648 (56.7)
 Myalgias 2489 (53.3)
 Fever 2236 (47.9)
 Arthralgia 2009 (43.0)
 Pharyngodynia 1659 (35.5)
 Anosmia 1056 (22.6)
 Dysgeusia 1015 (21.7)
 Rhinorrhea 1002 (21.5)
 Diarrhea 655 (14.0)
 Conjunctivitis 445 (9.5)
Main clinical conditions during hospitalization
 Duration of symptoms prior to admission 7 (4–10)
  0–5 days, n (%) 1730 (37)
  >5 days, n (%) 2899 (62.1)
  No registry, n (%) 41 (0.9)
 NEWS score at admission 3 (2–4)
  Green, n (%) 3592 (76.9)
  Yellow, n (%) 669 (14.3)
  Red, n (%) 154 (3.3)
  No registry, n (%) 255 (5.5)
 CALL score on admission 7 (4–8)
 Steroid treatment at hospitalization, n (%) 2057 (44.1)
 High-flow nasal cannula requirement, n (%) 710 (15.2)
 ICU admission, n (%) 216 (4.6)
 Invasive mechanical ventilation requirement, n (%) 212 (4.5)
 ICU duration, days 8 (5–14)
 Hospitalization stay, days 8 (6–12)
 Outcome, n (%)
  Discharge 4642 (99.4)
  Referred 28 (0.6)
Laboratory results during hospitalization
 Hemoglobin (mg/dL) 13.9 (12.8−14.9)
  Low hemoglobin (<12.5 mg/dL) 856 (18.3)
 D-dimer (ng/mL) 540 (340−1010)
 D-dimer categories, n (%)
  Normal level 2028 (43.4)
  500 to1000 ng/mL 934 (20)
  >1000 to <1500 ng/mL 392 (8.4)
  ⩾1500 ng/mL 614 (13.2)
 Ferritin (µg/L) 283.3 (116.5−591.6)
  High level (>336.2 µg/L), n (%) 1456 (31.2)
 Lactic dehydrogenase (UI/L) 206 (165−264)
  High level (>233 UI/L), n (%) 1435 (30.7)
 Absolute lymphocytes (×103 cells/μL) 1267.2 (861−1793.4)
  <1000 (×103 cells/μL), n (%) 1475 (31.6)
 Glucose (mg/dL) 126 (101−167)
  Glucose (>100 mg/dL), n (%) 2498 (53.5)

CALL, comorbidity, age, lymphocyte count, and lactate dehydrogenase; ICU, intensive care unit; NEWS, National Early Warning Score.

Data are presented as median (interquartile range) unless otherwise stated.